Brazil’s health regulator Anvisa has approved clinical trials of a Covid-19 vaccine candidate developed by researchers at University of Oxford in the UK and supported by AstraZeneca. The Federal University of Sao Paulo (Unifesp) will help conduct the study, which is set to begin this month and will enrol 2,000 participants.
Novavax has partnered with contract development and manufacturing organisation (CDMO) AGC Biologics for large-scale manufacturing of its Matrix-M adjuvant for its Covid-19 vaccine. AGC Biologics will focus on process development for scaled-up manufacturing of Matrix-M to boost Novavax’s capacity to deliver vaccine doses in 2020 and 2021.
Go deeper with GlobalData
The World Health Organization has said that the paused hydroxychloroquine portion of its Solidarity Trial will be resumed. The decision comes after the study’s Data Safety and Monitoring Committee reviewed trial data and recommended that it could continue without any modifications.
Revive Therapeutics has submitted an application to Health Canada to conduct a Phase III confirmatory clinical trial of Bucillamine to treat mild to moderate Covid-19. The trial will involve at least 210 patients and will mainly evaluate the drug’s impact on frequency of hospitalisation and mortality.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
